R&D Pipeline and Emerging PEGylated Therapies Driving Market...

bir ses eklendi Other

2026-03-24 12:49:35 -

R&D Pipeline and Emerging PEGylated Therapies Driving Market Expansion

The PEGylated Drugs Market is expanding rapidly as pharmaceutical companies increasingly adopt PEGylation technology to improve drug stability, solubility, and half-life. Polyethylene glycol (PEG) modification enhances therapeutic efficacy by extending circulation time and reducing immunogenicity, making it a preferred technique in biologics, oncology, autoimmune diseases, and chronic...

0 Yorumlar 0 hisse senetleri 212 Views 0 önizleme